Synthesis Capital Management | LaunchVic

Synthesis Capital Management

Investor

A closeup view of a microscope from a MedTech startup looking into something

Synthesis Capital Management, a spin out of the MedTech Actuator, have received a $300,000 grant from LaunchVic’s VC Support Program to launch a fund that will focus on investing in early-stage, deeptech medical, health and wellbeing-related ventures, from pre-seed to series A+.

Learn more